Health
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
Amglidia® has been approved by the European Medicines Agency (EMA) and is commercially available in EuropeStrong strategic fit with Eton's existing pediatric endocrinology focusAmglidia has been granted Orphan Drug Designation by the U.S. Food and Dr
By: manilatimes
- Nov 26 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS